Medical Devices Germany

Germany Hormone Testing at Home Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Germany Hormone Testing at Home Market Industry Trends and Forecast to 2034: Segmented by (Hormone, Sample, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Germany · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $29.7 Mn Placeholder estimate
Estimate 2025 $32.0 Mn 3.8% of the global market
Projected 2034 $63.5 Mn 98.2% Adds $31.5 Mn over 9 forecast years
CAGR 2025–2034 7.9% Faster than 58% of 173 Medical Devices markets here
Key players 5 Companies profiled
  • Germany is 3.78% of the global market.
  • In Europe, the largest is Germany (this report) at $32.0 Mn.
  • Fastest growing: Russia at 10.3% a year.
  • Germany ranks 1st of 6 by size in Europe.

Market size projection

Germany

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$31.5 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Hormone Testing at Home Market market size by year, Germany
YearMarket sizeChange that yearSince 2025
2024 (estimate) $29.7 Mn — —
2025 (base) $32.0 Mn +$2.3 Mn —
2026 (forecast) $34.5 Mn +$2.5 Mn +7.9%
2027 (forecast) $37.3 Mn +$2.7 Mn +16.4%
2028 (forecast) $40.2 Mn +$2.9 Mn +25.6%
2029 (forecast) $43.4 Mn +$3.2 Mn +35.5%
2030 (forecast) $46.8 Mn +$3.4 Mn +46.3%
2031 (forecast) $50.5 Mn +$3.7 Mn +57.8%
2032 (forecast) $54.5 Mn +$4.0 Mn +70.3%
2033 (forecast) $58.8 Mn +$4.3 Mn +83.7%
2034 (forecast) $63.5 Mn +$4.6 Mn +98.2%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $847.0 Mn
  2. US $379.4 Mn
  3. North America $355.7 Mn
  4. APAC $158.4 Mn
  5. Europe $135.3 Mn
  6. Canada $65.0 Mn
  7. China $61.6 Mn
  8. Japan $45.4 Mn
  9. Germany (this report) $32.0 Mn
  10. Latin America $33.3 Mn
  11. Middle East $31.4 Mn
  12. UK $22.9 Mn
  13. France $21.5 Mn
  14. Brazil $21.9 Mn
  15. Italy $17.2 Mn
  16. Ecuador $17.2 Mn
  17. Spain $16.3 Mn
  18. India $16.0 Mn
  19. Mexico $14.4 Mn
  20. Saudi Arabia $13.7 Mn
  21. Africa $12.5 Mn
  22. Australia $11.7 Mn
  23. New Zealand $8.2 Mn
  24. Russia $7.5 Mn
  25. South Africa $5.7 Mn
  26. UAE $4.8 Mn
  27. Egypt $2.4 Mn
  28. Philippines $2.1 Mn
  29. Hong Kong $1.4 Mn
  30. Malaysia $1.2 Mn
  31. Singapore $1.1 Mn
  32. Thailand $1.1 Mn
  33. Kenya $0.6 Mn

Report snapshot

Germany Hormone Testing at Home Market Analysis at a glance
Market size, 2025$32.0 Mn placeholder estimate
Forecast, 2034$63.5 Mn placeholder estimate
Growth (CAGR), 2025–20347.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsHormone, sample and end user (see all)
Key playersEverlywell, LetsGetChecked, Thorne, Mira, Hims & Hers Health (see all)
Regulator in GermanyBfArMSource: Federal Institute for Drugs and Medical Devices (BfArM). Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Germany Hormone Testing at Home Market Analysis Executive Summary

At-home hormone tests measure hormones such as estrogen, thyroid, cortisol and testosterone from finger-prick blood or saliva.

Key segments of the hormone Testing at Home market include hormone (Female Sex Hormones, Thyroid and Cortisol) and sample (Blood, Saliva and Urine).

Bar chart: Germany Hormone Testing at Home market size, 2024–2034, placeholder estimates. $29.7 Mn in 2024, $32.0 Mn in 2025 and $63.5 Mn in 2034, 7.9% CAGR.
Germany Hormone Testing at Home market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Germany Hormone Testing at Home Market Dynamics

Market Growth Drivers

Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the hormone Testing at Home market. New products designed around women's biology and digital care are improving access.

Opportunity

Femtech, personalised care and new treatments for under-served conditions open strong growth for the hormone Testing at Home market, especially as employers and payers add women's health benefits.

Market Restraints

Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the hormone Testing at Home market.

Competitive Landscape for Hormone Testing at Home Market in Germany

The hormone Testing at Home market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Hormone Testing at Home Market in Germany

Hormone Testing at Home in Germany: rules and payment

Medical devices need CE marking under the EU Medical Device Regulation (MDR); in Germany, BfArM assesses reports of incidents with them.⁠[1] Most people have statutory health insurance; the Federal Joint Committee (G-BA) decides what it covers and rates the added benefit of new medicines.⁠[2]

[1] Federal Institute for Drugs and Medical Devices (BfArM). Checked 14 Nov 2026.

[2] Federal Joint Committee (G-BA). Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how hormone Testing at Home products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Germany.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Hormone Testing at Home right now, from free public sources.

Latest research 4 papers since 2021 (worldwide)

  1. Association Between Hormone Variability and Anaerobic Performance in Recreationally Active Women: An Exploratory Study Using Mixed-Effect Location Scale Models. Journal of strength and conditioning research, 2026
  2. A Novel Approach to Characterization of the Female Hormone Profile: Feasibility and Research Application of Daily At-Home Urine Hormone Monitoring. Medicine and science in sports and exercise, 2026
  3. Menstrual tracking technologies and fertility: evaluating accuracy, utility, and impact on time to pregnancy. Fertility and sterility, 2026
  4. Evaluation of at-home serum anti-Müllerian hormone testing: a head-to-head comparison study. Reproductive biology and endocrinology : RB&E, 2022
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Hormone Testing at Home in context

Germany compared

  • Health spending per person: 6,849 US$ per person (2024). World: 1,317 US$ per person (2023). Highest of the 6 countries we cover in Europe.[1]
  • Doctors: 4.53 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 2nd highest of the 6 countries we cover in Europe.[2]
  • People aged 65 and over: 23.7% of people (2025). World: 10.4% of people (2025). 2nd highest of the 6 countries we cover in Europe.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Hormone Testing at Home market in Germany?
Placeholder estimate: about $32.0 Mn in 2025, rising to about $63.5 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Hormone Testing at Home market in Germany growing?
Placeholder estimate: about 7.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Hormone Testing at Home market report cover?
The report splits the market by hormone (Female Sex Hormones, Thyroid, Cortisol, Testosterone), sample (Blood, Saliva, Urine) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Hormone Testing at Home market?
Key players include Everlywell, LetsGetChecked, Thorne, Mira and Hims & Hers Health.
What is driving the Hormone Testing at Home market?
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the hormone Testing at Home market. New products designed around women's biology and digital care are improving access.
Who regulates Hormone Testing at Home in Germany?
Medical devices need CE marking under the EU Medical Device Regulation (MDR); in Germany, BfArM assesses reports of incidents with them. Source: Federal Institute for Drugs and Medical Devices (BfArM). Checked 14 Nov 2026.
How is healthcare paid for in Germany?
Most people have statutory health insurance; the Federal Joint Committee (G-BA) decides what it covers and rates the added benefit of new medicines. Source: Federal Joint Committee (G-BA). Checked 14 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Hormone Testing at Home in Germany? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Women's Health Supplements: A Growing FocusAnaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth… Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions… Molecular Point-of-Care Tests: Lab Accuracy, Clinic SpeedTB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade…
Back to Catalogue
Keep exploring

Related Medical Devices reports in Germany

See all
Same topic, other categories

Related on women's health and diagnostics and lab testing

See the topic